Partnership agreements for CROs and eClinical technology providers can be as beneficial as sponsor/CRO partnerships.
Graham Bunn
Advertisement
Graham Bunn is the vice president, eClinical Business for Quintiles Limited, Station House, Market Street Bracknell Berkshire, RG12 1HX, UK, +44 1344 708000, fax +44 1344 708300, email: graham.bunn@ quintiles.com.
Articles by Graham Bunn
After years of pilot trials, the pharmaceutical industry still sees EDC as something new. Here are two approaches toward making EDC into business as usual.
Advertisement
Latest Updated Articles
Some Things Work Better as PartnershipsPublished: April 1st 2013 | Updated:
- Scaling up EDC: How to Move Away from Paper Trials
Published: August 2nd 2002 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
2
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
3
Accelerating Development Through Parallel Execution and Rigorous Quality Controls
4
ACT Brief Weekly Recap: AI Innovation, Industry Resilience, and Supply Chain Readiness
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
